Managers / Q2 2025 · view latest →
Samjo Management, LLC
CIK 0001986590 · 880 THIRD AVENUE, 16TH FLOOR, NEW YORK, NY, 10022 · 212 419-3924
Summary
Samjo Management, LLC reported $237M in U.S.-listed holdings across 84 positions for Q2 2025.
Its largest position, THRY, represents 5.3% of the portfolio.
Compared with Q1 2025, the fund opened 3 new positions and exited 2.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 87.0% · $206M
- Other · 9.6% · $23M
- ADR · 1.8% · $4M
- MLP · 0.9% · $2M
- REIT · 0.7% · $2M
- Other · 0.0% · $101,557
Quarter-over-Quarter Changes full breakdown →
vs Q1 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| WMBWILLIAMS COS INC | NEW | +13.1K | 13.1K | +$820,927 | $820,927 |
| CCCCCC INTELLIGENT SOLUTIONS HL | NEW | +70.0K | 70.0K | +$658,700 | $658,700 |
| IBMINTERNATIONAL BUSINESS MACHS | NEW | +800 | 800 | +$235,824 | $235,824 |
| RMNIRIMINI STR INC DEL | ADDED | +285.0K | 485.0K | +$1M | $2M |
| SPROTT FDS TR | SOLD OUT | −24.2K | 0 | −$785,535 | $0 |
| UNHUNITEDHEALTH GROUP INC | SOLD OUT | −500 | 0 | −$261,875 | $0 |
| BIODESIX INC | TRIMMED | −2.41M | 25.0K | −$2M | $7,055 |
| SVCOSILVACO GROUP INC | TRIMMED | −510.6K | 155.1K | −$2M | $732,072 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2025
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $231M | 84 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $259M | 85 | Feb 17, 2026 | RESTATEMENT | changes · EDGAR ↗ |
| Q3 2025 | $262M | 86 | Nov 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $237M | 84 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $236M | 83 | May 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $265M | 78 | Feb 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $290M | 74 | Nov 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $268M | 73 | Aug 13, 2024 | RESTATEMENT | changes · EDGAR ↗ |
| Q1 2024 | $284M | 75 | May 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $282M | 68 | Feb 9, 2024 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.